How private equity can drive innovation in the healthcare industry
Federico Spandonaro
DOI: https://doi.org/
The article has been translated automatically. Note
1
Dentons (2023), Private equity’s growing role in M&A has clear benefits, https://www.dentons.com/en/insights/ articles/2023/august/7/private-equitys-growing-role-in-m- and-a-has-clear-benefits.
2
Bain & Company (2023), Global healthcare pri- vate equity and M&A Report 2023, https://www.bain.com/ globalassets/noindex/2023/bain_report_global_healthcare_ private_equity_and_ma_2023.pdf.
3
European Federation of Pharmaceuticals Industries and Associations (2022), The pharmaceutical industry in fig- ures, https://www.efpia.eu/media/637143/the-pharmaceuti- cal-industry-in-figures-2022.pdf.
4
Bain & Company (2023), Global healthcare private eq- uity and M&A Report 2023, https://www.bain.com/globalas- sets/noindex/2023/bain_report_global_healthcare_private_ equity_and_ma_2023.pdf.
5
Healthcare Information and Management Sys- tems Society (2021), The 2021 future of healthcare report, https://www.himss.org/resources/future-healthcare-re- port-exploring-healthcare-stakeholders-expecta- tions-next-chapter.
6
Bain & Company (2023), 2023 Healthcare Provider IT Report: Doubling Down on Innovation, https://www.bain. com/insights/2023-healthcare-provider-it-report-dou- bling-down-on-innovation/.
7
Davies N. (2021), How biopharma and CROs can create value in a shift to decentralized trials, https://www.ey.com/ en_us/life-sciences/how-biopharma-and-cros-can-create- value-in-a-shift-to-decentralized-trials.
8
Bain & Company (2023), Global healthcare private eq- uity and M&A Report 2023, https://www.bain.com/globalas- sets/noindex/2023/bain_report_global_healthcare_private_ equity_and_ma_2023.pdf.
9
Invivo (2007), Biomet’s rebirth, https://invivo.citeline. com/IV002987/Biomets-Rebirth.
10
Elvidge S. (2018), J&J to sell Lifescan, dropping out of diabetes diagnostics, https://www.biopharmadive.com/ news/jj-to-sell-lifescan-dropping-out-of-diabetes-diagnos- tics/519401.
11
Platinum Equity (2021), Why Platinum Equity acqui- sition of LifeScan was ‘rebirth’ for healthcare leader in glucose management, https://www.platinumequity.com/news/why- platinum-equity-acquisition-of-lifescan-was-rebirth-for- healthcare-leader-in-glucose-management/.
12
Center for the business of health (2023), Private Eq- uity in healthcare: exploring the challenges and opportunities, https://cboh.unc.edu/wp-content/uploads/2023/07/Pri- vate-Equity-in-Healthcare-07062023.pdf.
13
Atul Gupta, Sabrina T. Howell, Constantine Yan- nelis, Abhinav Gupta (2021), Owner incentives and perfor- mance in healthcare: private equity investment in nursing homes https://www.nber.org/papers/w28474.
14
American Investment Council (2022), Improving medical technologies: private equity’s role in life sciences https:// www.investmentcouncil.org/wp-content/uploads/2022/04/ aic-life-sciences-report2-1.pdf.
